Trends in Cardiovascular Medicine
Volume 17, Issue 2 , Pages 69-75, February 2007

Selective Depletion of Macrophages in Atherosclerotic Plaques via Macrophage-Specific Initiation of Cell Death

  • Wim Martinet

      Affiliations

    • Division of Pharmacology, University of Antwerp, B-2610 Wilrijk, Belgium
    • Corresponding Author InformationAddress correspondence to: Dr. Wim Martinet, Division of Pharmacology, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, Belgium. Tel.: (+32) 3-820-27-10; fax: (+32) 3-820-25-67.
  • ,
  • Stefan Verheye

      Affiliations

    • Antwerp Cardiovascular Institute Middelheim, B-2020 Antwerp, Belgium
  • ,
  • Guido R.Y. De Meyer

      Affiliations

    • Division of Pharmacology, University of Antwerp, B-2610 Wilrijk, Belgium

Macrophages play a central role in atherosclerotic plaque destabilization, leading to acute coronary syndromes and sudden death. Removal of macrophages from plaques via pharmacological therapy may therefore represent a promising approach to stabilize vulnerable, rupture-prone lesions. In this review, we summarize the current therapeutic means to induce macrophage cell death in atherosclerotic plaques without affecting smooth muscle cell viability, and their potential pitfalls.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1050-1738(07)00005-9

doi:10.1016/j.tcm.2006.12.004

Trends in Cardiovascular Medicine
Volume 17, Issue 2 , Pages 69-75, February 2007